schließen (X)

News

16.05.2017
CUTERA Launches truSculpt® 3D … A New Dimension in Body Sculpting

BRISBANE, Calif., May 16, 2017 (GLOBE NEWSWIRE) — CUTERA (Nasdaq:CUTR), a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, announced the launch of truSculpt® 3D, the newest advancement in non-surgical body sculpting, offering up to 24 percent fat reduction in a single treatment.   truSculpt 3D utilizes a controlled, monopolar radio frequency (RF) technology at 2 MHz to deliver […]

Read more >


24.04.2017
The Product Family of Asclepion Laser Technologies: „Made in Germany“

Asclepion Laser Technologies offers different technologies for a multitude of aesthetic and medical treatments. With new products and follow up models of almost legendary systems like the MCL29 Dermablate, RubyStar, QuadroStar or MeDioStar, Asclepion picks up the link to the success story of laser technology “Made in Germany”.     MeDioStar NeXT Family – High-Performance […]

Read more >


24.04.2017
Hologic Completes Acquisition of Cynosure

„We are pleased to complete our acquisition of Cynosure, and look forward to working with Michael Davin and the entire Cynosure team to achieve even greater success in the large, rapidly growing medical aesthetics market,“ said Steve MacMillan, Hologic‘s Chairman, President and Chief Executive Officer. „Acquiring Cynosure, combined with divesting our blood screening business, fundamentally reshapes our business portfolio and makes us […]

Read more >


01.11.2016
Australian Medical Board issues guidelines on cosmetic medical and surgical procedures

The Medical Board of Australia has issued guidelines for medical practitioners who perform cosmetic medical and surgical procedures.     ‘The guidelines will help keep patients safe, without imposing an unreasonable regulatory burden on practitioners,’ said Board Chair, Dr Joanna Flynn AM. They apply to all medical practitioners, including specialist plastic surgeons, cosmetic surgeons and […]

Read more >


21.09.2016
Cynosure Receives Approval to Market SculpSure® in South Korea

“MFDS approval of SculpSure is another major step in our international growth strategy for this breakthrough non-invasive fat-reduction treatment,” said Cynosure President and Chief Executive Officer Michael Davin. “As one of the world’s fastest-growing medical aesthetic regions, the Asia Pacific market is an important one for SculpSure and our entire product portfolio. Our Asia-Pac subsidiaries […]

Read more >


13.07.2016
Cynosure to Ring NASDAQ Stock Market Closing Bell to Celebrate 25 Year Anniversary

Cynosure, Inc. (NASDAQ: CYNO) today announced that President and CEO Michael Davin, along with other members of the Company’s management team, will ring the Closing Bell at the NASDAQ Stock Market on Wednesday, July 27, 2016 to celebrate its 25th anniversary. Cynosure was founded by the late Horace Furumoto, PhD, a pioneer in the field […]

Read more >


05.07.2016
Heat for wounds – water-filtered infrared-A (wIRA) assists wound healing

Water-filtered infrared-A (wIRA) is a special form of heat radiation with high tissue penetration and a low thermal load to the skin surface, see Figure. wIRA promotes healing of acute and chronic wounds both by thermal and thermic as well as by non-thermal and non-thermic cellular effects. wIRA corresponds to the major part of the […]

Read more >


08.06.2016
Natural killer cells have a memory

Researchers at the University of Bonn and the Ludwig-Maximilians-Universität of Munich have decoded a new mechanism of how the immune system can specifically attack pigmented cells of the skin. It was previously believed that natural killer cells did not have an immunological memory for the body’s own tissues. However, the scientists have now showed that […]

Read more >


24.05.2016
Almirall and Bicosome enter into a collaboration and sublicense agreement for the development of topical drug delivery formulations

Almirall S.A., the global pharmaceutical company based in Barcelona, and Bicosome, a start-up company that develops and commercializes high performance cosmetic and dermopharmaceutical ingredients, announced that they have entered into a research, collaboration and sublicense agreement for the development of multiple topical dermatological products, based upon Bicosome’s proprietary patented delivery technology platform, Bicosome® Technology. In […]

Read more >


18.05.2016
Almirall’s Q1 results 2016: on track to achieve yearly guidance

– Net Sales +2.7%, benefiting from contribution of new businesses – Growth driven by Dermatology +13.3%, which now accounts for 43% of sales vs. 39% in Q1 15 – Product mix drove Gross Margin improvement of +40bps – Integration of new businesses on track – R&D pipeline continues to progress: 3 Phase III programs – […]

Read more >


Login

Lost your password?